Breaking News Instant updates and real-time market news.

ALNY

Alnylam

$100.76

0.01 (0.01%)

07:25
04/14/18
04/14
07:25
04/14/18
07:25

Alnylam to hold a conference call

Management discusses the new results from the Phase 1 and Phase 1/2 open-label extension (OLE) studies of Givosiran on a conference call to be held on April 14 at 8 am. Webcast Link

  • 14

    Apr

  • 20

    Apr

  • 08

    May

  • 30

    May

  • 11

    Aug

ALNY Alnylam
$100.76

0.01 (0.01%)

04/03/18
JMPS
04/03/18
NO CHANGE
Target $207
JMPS
Outperform
JMP Securities says Alnylam selloff an 'extreme overreaction' to competitor data
After speaking to Alnylam (ALNY) management about competitor Pfizer's (PFE) positive top-line trial results for tafamidis in patients with transthyretin cardiomyopathy, JMP Securities analyst Michael King said Alnylam believes patisiran has a superior competitive profile compared to tafamidis in patients with hATTR-FAP. He views the selloff in Alnylam shares as "an extreme overreaction" to the presence of a competitor, reminding investors of recent International Symposium on Amyloidosis data that he said suggest that ALN-TTRsc02 will be well positioned with respect to tafamidis. King reiterates his Outperform rating and $207 price target on Alnylam.
04/02/18
JEFF
04/02/18
NO CHANGE
JEFF
Buy
Alnylam weakness on Pfizer data a buying opportunity, says Jefferies
Jefferies analyst Maury Raycroft noted that Alnylam (ALNY) fell by over 8% on Thursday after Pfizer (PFE) announced that the phase 3 ATTR-ACT trial assessing tafamidis in TTR-CM met its primary endpoint and that Alnylam shares are trailing the iShares Nasdaq Biotechnology Index (IBB) again today. While he thinks the tafamidis data provide important clinical outcome results that support the need for treatment and benefit in TTR-CM, he also continues to believe the benefits of knocking down/depleting TTR in earlier-stage patients, as Alnylam's patisiran is meant to do, will lead to better objective improvements, Raycroft tells investors. The analyst, who recommends investors buy Alnylam amid the weakness, keeps a Buy rating on the stock.
03/29/18
PIPR
03/29/18
NO CHANGE
Target $182
PIPR
Overweight
Piper says Pfizer's tafamidis poses minimal threat to Alnylam's patisiran
Piper Jaffray analyst Edward Tenthoff attributes weakness in shares of Alnylam (ALNY) to Pfizer (PFE) having reported that tafamidis achieved a significant reduction in all-cause mortality and frequency of cardiovascular-related hospitalizations vs. placebo at 30 months in a trial of ATTR cardiomyopathy patients. However, he would be a buyer of Alnylam amid the pullback, as he sees a minimal competitive threat, contending that patisiran's mechanism of mRNA knockdown is more potent than tafamidis' stabilization. The analyst, who expects patisiran to receive FDA approval broadly in ATTR amyloidosis polyneuropathy and cardiomyopathy by its PDUFA date of August 11, maintains an Overweight rating and $182 price target on Alnylam.
03/28/18
EVER
03/28/18
INITIATION
Target $143
EVER
In Line
Alnylam initiated with an In Line at Evercore ISI
Evercore ISI started Alnylam Pharmaceuticals with an In Line rating and $143 price target.

TODAY'S FREE FLY STORIES

11:05
11/21/18
11/21
11:05
11/21/18
11:05
General news
Euro$ interest rate futures were checked lower »

Euro$ interest rate…

11:05
11/21/18
11/21
11:05
11/21/18
11:05
General news
FX Action: USD-CAD »

FX Action: USD-CAD ticked…

DE

Deere

$143.73

5.24 (3.78%)

11:00
11/21/18
11/21
11:00
11/21/18
11:00
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere says November…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

ALT

Altimmune

$3.21

0.2 (6.64%)

10:58
11/21/18
11/21
10:58
11/21/18
10:58
Hot Stocks
Altimmune granted European patent for influenza antigen delivery vectors »

A post to the European…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYMX

Nymox

$1.81

0.07 (4.02%)

10:58
11/21/18
11/21
10:58
11/21/18
10:58
Hot Stocks
Nymox director James George Robinson buys 9K shares of company stock »

Nymox director James…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QEP

QEP Resources

$8.81

-0.3 (-3.29%)

10:55
11/21/18
11/21
10:55
11/21/18
10:55
Options
QEP Resources put volume heavy and directionally bearish »

Bearish flow noted in QEP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLW

Corning

$31.21

0.37 (1.20%)

, T

AT&T

$29.82

0.41 (1.39%)

10:55
11/21/18
11/21
10:55
11/21/18
10:55
Conference/Events
UBS optical/networking equip analyst to hold analyst/industry conference call »

Optical & Networking…

GLW

Corning

$31.21

0.37 (1.20%)

T

AT&T

$29.82

0.41 (1.39%)

VZ

Verizon

$59.30

-0.16 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 26

    Nov

  • 03

    Dec

GPS

Gap

$25.60

0.95 (3.85%)

10:46
11/21/18
11/21
10:46
11/21/18
10:46
OnTheFly
Gap rises amid potential store closures as namesake brand sales continue slide »

Shares of Gap (GPS) are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

10:45
11/21/18
11/21
10:45
11/21/18
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
11/21/18
11/21
10:45
11/21/18
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

KSS

Kohl's

$65.28

0.83 (1.29%)

10:40
11/21/18
11/21
10:40
11/21/18
10:40
Options
Bullish call spread in Kohls after recent weakness in shares »

Bullish call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
11/21/18
11/21
10:40
11/21/18
10:40
General news
The U.S. 1.4% October existing home sales rise »

The U.S. 1.4% October…

10:40
11/21/18
11/21
10:40
11/21/18
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DE

Deere

$145.63

7.14 (5.16%)

10:37
11/21/18
11/21
10:37
11/21/18
10:37
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere raises 2022…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

DE

Deere

$144.30

5.81 (4.20%)

10:32
11/21/18
11/21
10:32
11/21/18
10:32
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere sees grain demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

10:31
11/21/18
11/21
10:31
11/21/18
10:31
General news
Crude inventories for week of November 16 »

Crude oil inventories…

JNJ

Johnson & Johnson

$143.12

-3.32 (-2.27%)

10:30
11/21/18
11/21
10:30
11/21/18
10:30
Options
J&J puts active as shares see relative weakness »

J&J puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

10:30
11/21/18
11/21
10:30
11/21/18
10:30
General news
FX Action: The dollar »

FX Action: The dollar…

DE

Deere

$143.26

4.77 (3.44%)

10:29
11/21/18
11/21
10:29
11/21/18
10:29
Hot Stocks
Deere says U.S. farmers, dealers 'cautiously optimistic' »

Says record yields,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

AVGO

Broadcom

$229.32

1.63 (0.72%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:28
11/21/18
11/21
10:28
11/21/18
10:28
Periodicals
Breaking Periodicals news story on Broadcom, Volkswagen »

Broadcom said to settle…

AVGO

Broadcom

$229.32

1.63 (0.72%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMZN

Amazon.com

$1,520.59

24.99 (1.67%)

10:27
11/21/18
11/21
10:27
11/21/18
10:27
Periodicals
Amazon contacting some users about error that exposed emails, The Verge says »

Amazon has been emailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

10:25
11/21/18
11/21
10:25
11/21/18
10:25
General news
U.S. leading index rose 0.1% to 112.1 in October, another record high »

U.S. leading index rose…

TLC

Taiwan Liposome

$0.00

(0.00%)

10:21
11/21/18
11/21
10:21
11/21/18
10:21
Syndicate
Taiwan Liposome opens at $6.06, IPO priced at $5.80 per share »

Taiwan Liposome (TLC)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

NVDA

Nvidia

$150.33

1.19 (0.80%)

10:20
11/21/18
11/21
10:20
11/21/18
10:20
Technical Analysis
Technical Take: Nvidia goes negative on the day »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
U.S. October existing home sales bounced 1.4% to 5.220 M »

U.S. October existing…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.